Pharmaceuticals in the Environment Sources, Fate, Effects and Risks / edited by Klaus Kümmerer.

Saved in:
Bibliographic Details
Corporate Author: SpringerLink (Online service)
Other Authors: Kümmerer, Klaus (Editor)
Format: eBook
Language:English
Published: Berlin, Heidelberg : Springer Berlin Heidelberg : Imprint: Springer, 2001.
Edition:1st ed. 2001.
Series:Springer eBook Collection.
Subjects:
Online Access:Click to view e-book
Holy Cross Note:Loaded electronically.
Electronic access restricted to members of the Holy Cross Community.
Table of Contents:
  • 1 Introduction: Pharmaceuticals in the Environment
  • I Emission, Occurrence, Fate and Effects
  • 2 Effects on Pharmaceuticals in the Environment — an Overview and Principle Considerations
  • 3 Environmental Loads and Detection of Pharmaceuticals in Italy
  • 4 Emission and Biodegradability of Pharmaceuticals, Contrast Media, Disinfectants and AOX from Hospitals
  • 5 Emissions from Clinical-Chemical Laboratories
  • 6 Pharmaceuticals in the Environment: Focus on 17?-ethinyloestradiol
  • 7 What Do We Know about Antibiotics in the Environment?
  • 8 Antibiotics in the Environment: Zinc Bacitracin — Environmental Toxicity and Breakdown
  • 9 Pharmaceutical Residues in the Aquatic Environment and their Significance for Drinking Water Production
  • 10 Pharmaceuticals as Environmental Contaminants: Modelling Distribution and Fate
  • II Risk Assessment
  • 11 Risk Assessment of Organic Xenobiotics in the Environment
  • 12 Ecotoxicological Evaluation of Pharmaceuticals
  • 13 Worst-Case Estimations of Predicted Environmental Soil Concentrations (PEC) of Selected Veterinary Antibiotics and Residues Used in Danish Agriculture
  • 14 Regulatory and Methodological Aspects Concerning the Risk Assessment for Medicinal Products; Need for Research
  • 15 A Data-based Perspective on the Environmental Risk Assessment of Human Pharmaceuticals I — Collation of Available Ecotoxicity Data
  • 16 A Data Based Perspective on the Environmental Risk Assessment of Human Pharmaceuticals II — Aquatic Risk Characterisation
  • 17 A Data Based Perspective on the Environmental Risk Assessment of Human Pharmaceuticals III — Indirect Human Exposure
  • 18 The ECO-SHADOW Concept — A New Way of Following Environmental Impacts of Antimicrobials
  • III Perspectives
  • 19 Present Knowledge and Need for Further Research.